• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. ULTRAFLEX IAB: 7.5FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. ULTRAFLEX IAB: 7.5FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN000260
Device Problem Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/19/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the intra-aortic balloon (iab) after two times of normal implantation of the dilator and sheath, when being placed nearly half of the sheath, the catheter could not advance normally.After two times of vacuum evacuation, the catheter was withdrawn horizontally and placed along the spring wire guide (swg).As a result, a new catheter was used to complete the treatment.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Manufacturer Narrative
(b)(4).The reported complaint of iab insertion difficulty is not able to be confirmed.Teleflex did not receive the device for investigation.The root cause of the complaint is undetermined.If the product is returned at a later date, a full investigation of the sample will be completed.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risks.No further action required at this time.The reported complaint will be monitored for any developing trends.
 
Event Description
It was reported that the intra-aortic balloon (iab) after two times of normal implantation of the dilator and sheath, when being placed nearly half of the sheath, the catheter could not advance normally.After two times of vacuum evacuation, the catheter was withdrawn horizontally and placed along the spring wire guide (swg).As a result, a new catheter was used to complete the treatment.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Manufacturer Narrative
Qn#(b)(4).The reported complaint of iab insertion difficulty is not able to be confirmed.Teleflex did not receive the device for investigation.The root cause of the complaint is undetermined.If the product is returned at a later date, a full investigation of the sample will be completed.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risks.No further action required at this time.The reported complaint will be monitored for any developing trends.Other remarks: the complaint was reopened to investigate the device that was returned to teleflex.The reported complaint of iab insertion difficulty is confirmed.Upon return, the supplied teflon sheath was noted on the iab bladder.During the investigation, the teflon sheath was able to be moved towards the bifurcate without any difficulty; however, the central lumen was found bent near the distal tip of the catheter.A bent central lumen can result in difficulty inserting the iab into the patient.The root cause of the bent central lumen is undetermined.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.Teleflex assessed the risk for the reported complaint.There are no new or revised risks.This will be monitored for any developing trends.No further action required at this time.
 
Event Description
It was reported that the intra-aortic balloon (iab) after two times of normal implantation of the dilator and sheath, when being placed nearly half of the sheath, the catheter could not advance normally.After two times of vacuum evacuation, the catheter was withdrawn horizontally and placed along the spring wire guide (swg).As a result, a new catheter was used to complete the treatment.There was a report of delay in therapy.There was no report of patient complications, serious injury or death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX IAB: 7.5FR 40CC
Type of Device
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
MDR Report Key9135451
MDR Text Key182780517
Report Number3010532612-2019-00346
Device Sequence Number1
Product Code DSP
UDI-Device Identifier00801902026804
UDI-Public00801902026804
Combination Product (y/n)N
PMA/PMN Number
K000729
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 09/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2019
Device Model NumberIPN000260
Device Catalogue NumberIAB-06830-U
Device Lot Number18F17D0002
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/17/2020
Date Manufacturer Received03/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNKNOWN.; UNKNOWN.; UNKNOWN.
-
-